Revlimid (lenalidomide)

lenalidomide · Celgene/BMS

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Revlimid (lenalidomide), covering 2014-11-10 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR) [Phase 2]